<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    16888612
   </pmid>
   <datecreated>
    <year>
     2006
    </year>
    <month>
     08
    </month>
    <day>
     04
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2006
    </year>
    <month>
     08
    </month>
    <day>
     07
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2006
    </year>
    <month>
     09
    </month>
    <day>
     14
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Electronic">
      1545-8601
     </issn>
     <journalissue citedmedium="Internet">
      <volume>
       55
      </volume>
      <issue>
       RR-11
      </issue>
      <pubdate>
       <year>
        2006
       </year>
       <month>
        Aug
       </month>
       <day>
        4
       </day>
      </pubdate>
     </journalissue>
     <title>
      MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control
     </title>
     <isoabbreviation>
      MMWR Recomm Rep
     </isoabbreviation>
    </journal>
    <articletitle>
     Sexually transmitted diseases treatment guidelines, 2006.
    </articletitle>
    <pagination>
     <medlinepgn>
      1-94
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      These guidelines for the treatment of persons who have sexually transmitted diseases (STDs) were developed by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta, Georgia, during April 19-21, 2005. The information in this report updates the Sexually Transmitted Diseases Treatment Guidelines, 2002 (MMWR 2002;51[No. RR-6]). Included in these updated guidelines are an expanded diagnostic evaluation for cervicitis and trichomoniasis; new antimicrobial recommendations for trichomoniasis; additional data on the clinical efficacy of azithromycin for chlamydial infections in pregnancy; discussion of the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; emergence of lymphogranuloma venereum protocolitis among men who have sex with men (MSM); expanded discussion of the criteria for spinal fluid examination to evaluate for neurosyphilis; the emergence of azithromycin- resistant Treponema pallidum; increasing prevalence of quinolone-resistant Neisseria gonorrhoeae in MSM; revised discussion concerning the sexual transmission of hepatitis C; postexposure prophylaxis after sexual assault; and an expanded discussion of STD prevention approaches.
     </abstracttext>
    </abstract>
    <affiliation>
     Division of STD Prevention, National Center for HIV, Viral Hepatitis, STDs, and Tuberculosis Prevention, Atlanta, GA 30333, USA. kgw2@cdc.gov
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <collectivename>
       Centers for Disease Control and Prevention
      </collectivename>
     </author>
     <author validyn="Y">
      <lastname>
       Workowski
      </lastname>
      <forename>
       Kimberly A
      </forename>
      <initials>
       KA
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Berman
      </lastname>
      <forename>
       Stuart M
      </forename>
      <initials>
       SM
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Practice Guideline
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     United States
    </country>
    <medlineta>
     MMWR Recomm Rep
    </medlineta>
    <nlmuniqueid>
     101124922
    </nlmuniqueid>
    <issnlinking>
     1057-5987
    </issnlinking>
   </medlinejournalinfo>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="ErratumIn">
     <refsource>
      MMWR Recomm Rep. 2006 Sep 15;55(36):997.
     </refsource>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Sexually Transmitted Diseases
     </descriptorname>
     <qualifiername majortopicyn="N">
      diagnosis
     </qualifiername>
     <qualifiername majortopicyn="N">
      prevention &amp; control
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapy
     </qualifiername>
    </meshheading>
   </meshheadinglist>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2006
     </year>
     <month>
      8
     </month>
     <day>
      5
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2006
     </year>
     <month>
      8
     </month>
     <day>
      8
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2006
     </year>
     <month>
      8
     </month>
     <day>
      5
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pii">
     rr5511a1
    </articleid>
    <articleid idtype="pubmed">
     16888612
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

